Jacob Thomas
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Phagocytosis and Immune Regulation
- Immune cells in cancer
Papers in
- Oncology 29
- Cancer Immunotherapy and Biomarkers 14
- CAR-T cell therapy research 7
- HER2/EGFR in Cancer Research 4
-
- Cancer-related gene regulation 4
- Co-authors
- Fairooz F. Kabbinavar (1 shared paper)Anthony B. El-Khoueiry (22 shared papers)Gino K. In (5 shared papers)Jing Wang (1 shared paper)Nilofer S. Azad (4 shared papers)Fredric E. Wondisford (1 shared paper)Alphonse Chu (1 shared paper)Heinz‐Josef Lenz (4 shared papers)
- Journals
- Journal of Clinical Oncology (29 papers)Oncotarget (2 papers)Annals of Oncology (2 papers)Cancers (1 paper)Hematology/Oncology Clinics of North America (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Jacob Thomas
36 papers receiving 268 citations
Peers
Comparison fields: 5 of 58
- Oncology 126
- Immunology 77
- Cancer Research 33
- Pulmonary and Respiratory Medicine 69
- Molecular Biology 122
Countries citing papers authored by Jacob Thomas
This map shows the geographic impact of Jacob Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Thomas more than expected).
Fields of papers citing papers by Jacob Thomas
This network shows the impact of papers produced by Jacob Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Thomas. The network helps show where Jacob Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Jacob Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 46 | |
| 2 | 2020 | 34 | |
| 3 | 2021 | 22 | |
| 4 | 2024 | 21 | |
| 5 | 2020 | 21 | |
| 6 | 2021 | 14 | |
| 7 | 2022 | 12 | |
| 8 | 2020 | 11 | |
| 9 | 2024 | 9 | |
| 10 | 2020 | 9 | |
| 11 | 2023 | 8 | |
| 12 | 2022 | 7 | |
| 13 | 2023 | 7 | |
| 14 | 2023 | 7 | |
| 15 | 2023 | 6 | |
| 16 | 2022 | 4 | |
| 17 | 2024 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2023 | 3 | |
| 20 | 2021 | 3 |
About Jacob Thomas
Jacob Thomas is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Immunology, having authored 45 papers that have together received 279 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), CAR-T cell therapy research (7 papers), Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer Research and Treatments (4 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer-related gene regulation (4 papers). The work is most often cited by research in Oncology (126 citations), Immunology (77 citations), Cancer Research (33 citations), Pulmonary and Respiratory Medicine (69 citations) and Molecular Biology (122 citations). Jacob Thomas has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Fairooz F. Kabbinavar, Anthony B. El-Khoueiry, Gino K. In, Jing Wang, Nilofer S. Azad, Fredric E. Wondisford, Alphonse Chu, Heinz‐Josef Lenz, Jeffrey M. Farma and Syma Iqbal. Their work appears in journals such as Journal of Clinical Oncology, Oncotarget, Annals of Oncology, Cancers and Hematology/Oncology Clinics of North America.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.